Medtronic Aims To Bring Affordable/Portable HD To India By 2016
Espicom View: Chronic renal disease is become an increasing cause of morbidity in India, but the Indian Renal Foundation believes that healthcare expenditure in the country is not keeping pace. India has little in the way of infrastructure for renal care, and the cost of haemodialysis is currently unaffordable for the average citizen, estimated at around INR12,000-INR15,000 per month. Allowing patients to access haemodialysis in an affordable manner will be key in tackling rising cases.
Apollo Hospitals Enterprise and Medtronic have entered into a collaboration to bring to market an affordable and portable haemodialysis (HD) system in India to help improve access to care for end-stage renal disease (ESRD) patients who need renal replacement therapy (RRT).
This collaboration will use a Medtronic-developed technology platform, supported by clinical insight from Apollo. Both organisations envision an affordable and accessible healthcare delivery system that addresses the critical need for dialysis solutions in India. Both companies do not expect the collaboration to materially impact their earnings in the respective company's fiscal year.